| Title | Current Research in Pharmacology and Drug Discovery |
| Abbreviation | Curr. Res. Pharmacol. Drug Discov. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Animal Science and Zoology (Q1); Ecology, Evolution, Behavior and Systematics (Q1) |
| h-index | 14 |
| Overall Rank/Ranking | 5001 |
| SCImago Journal Rank (SJR) | 0.932 |
| Impact Score | 4.20 |
| Publisher | Elsevier B.V. |
| Country | Netherlands |
| ISSN | 25902571 |
| Best Quartile | Q1 |
| Coverage History | 2020-2023 |
Current Research in Pharmacology and Drug Discovery is a journal covering the technologies/fields/categories related to Animal Science and Zoology (Q1); Ecology, Evolution, Behavior and Systematics (Q1). It is published by Elsevier B.V.. The overall rank of Current Research in Pharmacology and Drug Discovery is 5001. According to SCImago Journal Rank (SJR), this journal is ranked 0.932. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 14. The best quartile for this journal is Q1.
The ISSN of Current Research in Pharmacology and Drug Discovery journal is 25902571. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Current Research in Pharmacology and Drug Discovery is cited by a total of 534 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Current Research in Pharmacology and Drug Discovery is 4.20, which is computed in 2024 as per its definition. Current Research in Pharmacology and Drug Discovery IF is increased by a factor of 0.23 and approximate percentage change is 5.79% when compared to preceding year 2022, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Current Research in Pharmacology and Drug Discovery is 4.20. If the same upward trend persists, Impact IF may rise in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 4.20 |
| 2022 | 3.97 |
| 2021 | 2.83 |
| 2020 | 0.00 |
Current Research in Pharmacology and Drug Discovery has an h-index of 14. It means 14 articles of this journal have more than 14 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Current Research in Pharmacology and Drug Discovery is 25902571. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Current Research in Pharmacology and Drug Discovery is 5001. According to SCImago Journal Rank (SJR), this journal is ranked 0.932. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 0.932 |
| 2022 | 0.727 |
| 2021 | |
| 2020 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 5001 |
| 2022 | 6776 |
| 2021 | 27185 |
| 2020 | 33103 |
Current Research in Pharmacology and Drug Discovery is published by Elsevier B.V.. It's publishing house is located in Netherlands. Coverage history of this journal is as following: 2020-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Current Research in Pharmacology and Drug Discovery is Curr. Res. Pharmacol. Drug Discov.. This abbreviation ('Curr. Res. Pharmacol. Drug Discov.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Animal Science and Zoology (Q1); Ecology, Evolution, Behavior and Systematics (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Current Research in Pharmacology and Drug Discovery latest impact IF is 4.20. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 4.20 (2023) and 0.00 (2020), respectively, in the last 4 years. Moreover, its average IS is 2.75 in the previous 4 years.
The Current Research in Pharmacology and Drug Discovery has an SJR (SCImago Journal Rank) of 0.932, according to the latest data. It is computed in the year 2024. In the past 4 years, this journal has recorded a range of SJR, with the highest being 0.932 in 2023 and the lowest being in 2021. Furthermore, the average SJR of the Current Research in Pharmacology and Drug Discovery over the previous 4-year period stands at 2.75.
The latest h-index of the Current Research in Pharmacology and Drug Discovery is 14.
The Current Research in Pharmacology and Drug Discovery is published by the Elsevier B.V., with its country of publication being the Netherlands.
The Current Research in Pharmacology and Drug Discovery is currently ranked 5001 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 4 years, this journal has experienced varying rankings, reaching its highest position of 5001 in 2023 and its lowest position of 33103 in 2020.
The standard ISO4 abbreviation for the Current Research in Pharmacology and Drug Discovery is Curr. Res. Pharmacol. Drug Discov..
Current Research in Pharmacology and Drug Discovery is classified as a journal that the Elsevier B.V. publishes.
The Current Research in Pharmacology and Drug Discovery encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Current Research in Pharmacology and Drug Discovery is assigned the following International Standard Serial Numbers (ISSN): 25902571.
The best quartile for the Current Research in Pharmacology and Drug Discovery is Q1 (2023).
The Current Research in Pharmacology and Drug Discovery coverage history can be summarized as follows: 2020-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Zeitschrift fur Germanistische Linguistik | journal | 14988 | Walter de Gruyter GmbH | 16 | 0.40 |
| Business: Theory and Practice | journal | 14643 | Vilnius Gediminas Technical University | 26 | 2.37 |
| Applied Ecology and Environmental Research | journal | 18145 | Corvinus University of Budapest | 43 | 0.77 |
| Istanbul University - Journal of Electrical and Electronics Engineering | journal | 24654 | University of Istanbul | 0 | 0.00 |
| Journal of Applied Business Research | journal | 25715 | CIBER Institute | 32 | 0.19 |
| British Journal of Special Education | journal | 16076 | Wiley-Blackwell Publishing Ltd | 44 | 0.78 |
| Libyan Studies | journal | 19526 | Cambridge University Press | 9 | 0.30 |
| Exploration Geophysics | journal | 13768 | Taylor and Francis Ltd. | 50 | 1.06 |
| Genes and Nutrition | journal | 5793 | BioMed Central Ltd | 65 | 3.42 |
| Proteomics - Clinical Applications | journal | 9438 | Wiley-VCH Verlag | 64 | 2.28 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 4.20 |
| 2022 | 3.97 |
| 2021 | 2.83 |
| 2020 | 0.00 |
